HomeACQUISITIONS and MERGERS

ACQUISITIONS and MERGERS

The Ensign Group Acquires Post-Acute Care Campus in Arizona

These acquisitions bring Ensign's growing portfolio to 226 healthcare operations, 24 of which also include assisted living operations, across thirteen states.  Ensign owns the real estate at 92 healthcare operations. 

Flow Forward Medical Acquired by Artio Medical

This stock-for-stock merger transaction in which Flow Forward Medical merged with and into Artio was approved by the Board of Directors and stockholders of both companies. The transaction closed on June 8, 2020.  

H.I.G. Capital Reports Vernacare Acquires Frontier Medical’s Infection Prevention Business

The acquired businesses are industry-leaders in the infection prevention market providing an extensive range of sharps and clinical waste disposal solutions.

RapidAI Acquires EndoVantage

In 2019, RapidAI introduced Rapid ICH, the next step in AI-powered imaging technology for hemorrhages. Now with the acquisition of EndoVantage, the company will also add a concentration on aneurysm.

Nordson Corporation Acquires Fluortek, Inc.

Fluortek will become part of the Nordson MEDICAL product line within Nordson’s Advanced Technology Solutions segment.

Conventus Orthopaedics Acquires Flower Orthopedics

Conventus intends to continue to aggressively pursue new and innovative orthopedic technologies that are clinically relevant to surgeons, hospitals, and ambulatory surgery centers. 

Smiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access Offering

Access Scientific is a broad-spectrum vascular access and infection prevention company that manufactures the POWERWAND™ midline and extended dwell catheters.

Minerva Surgical Announces Acquisition Closing of Boston Scientific Intrauterine Health Products

Minerva's combined product line will provide healthcare practitioners with the most complete and trusted product portfolio for treating Abnormal Uterine Bleeding (AUB).

TearLab Announces Acquisition By Accelmed and Related $25 Million Investment

TearLab notes the proceeds from the AP-II investment will be used to pay down a portion of TearLab's existing debt, and fund both organic and inorganic growth opportunities.